Transplantation Using Hepatitis C Positive Donors, A Safety Trial

Conditions:   Lung Transplant Infection;   Heart Transplant Infection;   Kidney Transplant Infection;   Kidney Pancreas Infection;   Hepatitis C Interventions:   Drug: Glecaprevir 300 MG / Pibrentasvir 120 MG Oral Tablet;   Drug: Ezetimibe 10Mg Oral Tablet;   Device: Ex Vivo Lung Perfusion Sponsors:   Jordan Feld;   University Health Network, Toronto Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials